Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called \"superbugs\" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs). Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
Let me give you a couple of examples that make more sense. In 2012, so four years ago, we had raised about $12 million. We spend about $25,000 with an outside engineering firm. It took a couple of months. Had some really educated engineers come up with kind of a boring plastic tube. Boring to y...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
